Tower Research Capital LLC (Trc) Guardant Health, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,500 shares of GH stock, worth $553,380. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,500

Previous 3,353 242.98%

Holding current value

$553,380

Previous $76,000 361.84%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$20.2 - $38.11 $164,569 - $310,482	8,147 Added 242.98%	11,500 $351,000
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $350,556 - $570,478	-15,720 Reduced 82.42%	3,353 $76,000
Q2 2024 Aug 13, 2024	BUY	$16.07 - $31.84 $295,912 - $586,301	18,414 Added 2794.23%	19,073 $550,000
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $433,337 - $680,742	-25,297 Reduced 97.46%	659 $13,000
Q4 2023 Feb 13, 2024	BUY	$21.58 - $29.5 $528,062 - $721,865	24,470 Added 1646.7%	25,956 $702,000
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $51,471 - $79,740	-1,995 Reduced 57.31%	1,486 $44,000
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $598,067 - $1.09 Million	-28,561 Reduced 89.14%	3,481 $124,000
Q1 2023 May 09, 2023	BUY	$22.92 - $33.76 $714,645 - $1.05 Million	31,180 Added 3617.17%	32,042 $751,000
Q4 2022 Feb 10, 2023	SELL	$25.44 - $59.78 $31,443 - $73,888	-1,236 Reduced 58.91%	862 $23,000
Q3 2022 Nov 10, 2022	SELL	$43.66 - $61.0 $33,399 - $46,665	-765 Reduced 26.72%	2,098 $113,000
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $40,751 - $109,372	1,414 Added 97.58%	2,863 $116,000
Q1 2022 May 12, 2022	SELL	$48.25 - $100.49 $182,433 - $379,952	-3,781 Reduced 72.29%	1,449 $96,000
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $269,234 - $365,505	3,035 Added 138.27%	5,230 $523,000
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $257,789 - $344,963	-2,610 Reduced 54.32%	2,195 $275,000
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $436,994 - $659,572	3,981 Added 483.13%	4,805 $597,000
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $411,228 - $579,746	-3,237 Reduced 79.71%	824 $126,000
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $331,867 - $451,287	3,320 Added 448.04%	4,061 $523,000
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $42,248 - $58,806	526 Added 244.65%	741 $83,000
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $13,005 - $20,962	215 New	215 $17,000
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $5,431 - $8,170	-92 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$59.49 - $82.78 $3,390 - $4,718	57 Added 162.86%	92 $7,000
Q3 2019 Nov 05, 2019	BUY	$62.59 - $110.3 $2,190 - $3,860	35 New	35 $2,000
Q2 2019 Aug 13, 2019	SELL	$63.94 - $91.11 $136,575 - $194,610	-2,136 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$34.3 - $97.98 $73,161 - $208,991	2,133 Added 71100.0%	2,136 $164,000
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $87 - $138	3 New	3 $0

Others Institutions Holding GH

# of Institutions

340

Shares Held

119M

Call Options Held

1.11M

Put Options Held

2.07M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.92B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Guardant Health, Inc. Transaction History